Full Text:
영남의대학술지 Vol.28 No.1 p13-19, June2011
Review
폐렴원인균으로서 약제내성 폐렴사슬알균(Drug-resistant Streptococcus pneumoniae)의 현황과 임상적 의미
Clinical Implications of Drug-Resistant Streptococcus pneumoniae as a Cause of Community Acquired Pneumonia
신경철
영남대학교 의과대학 내과학교실
교신저자：신경철, 대구광역시 남구 대명5동 317-1, 영남대학교 의과대학 내과학교실
Tel: (053) 620-3850, Fax: (053) 654- 8386
E-mail : shin1014@ynu.ac.kr
June 30, 2011
Abstract
The emergence of antibiotic-resistant pathogens is a serious clinical problem in the treatment of infectious diseases that increase mortality, morbidity, hospitalization length, and the cost of healthcare. In particular, Streptococcus pneumoniae is a major etiologic pathogen of pneumonia, sinusitis, otitis media, and meningitis. As the definition of penicillin resistance to S. pneumoniae was recently changed, macrolide-resistant S. pneumoniae is a major resistant pathogen in the community. Infections caused by antibiotic-resistant strains are associated with incorrect use of antibiotics and critical clinical outcomes. For the appropriate use of antibiotics to treat infections, physicians always should have up-to-date information on the current epidemiologic status of antibiotic resistance for common pathogens and their susceptibility to antimicrobials. Appropriate selection of antimicrobials, strict control of infection, vaccination, and development of a feasible national policy of infection control are important strategies for the control of antimicrobial resistance. This review article focuses on the current status of antibiotic-resistant S. pneumoniae in community-acquired pneumonia in Korea.
Key Words: Streptococcus pneumonia, Drug-resistant, Pneumonia
References
	1. Lee HJ, Park JY, Jang SH, Kim JH, Kim EC, Choi KW. High incidence of resistant to multiple antimicrobials in clinical isolates of Streptococcus pneumoniae from a university hospital in Korea. Clin Infect Dis 1995;20: 826-35.
	2. Song JH, Chung DR, Peck KR, Yang JW, Pai CH. Clinical characteristics of penicillin- resistance Streptococcus pneumoniae (PRSP) [abstract]. 35th Interscience Conference on Antimicrobial Agents and Chemotherapy; 1995 Sep 17-20; San Francisco, USA. 1995. p. 40.
	3. Chong Y, Lee K, Kwon OH, Henrichsen J. Capsular types and antimicrobials resistance Streptococcus pneumoniae isolated in Korea. Eur J Clin Microbiol Infect Dis. 1995;14:528-31.
	4. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing, Fifth informational supplement, M100-55. Villanova, PA: National Committee for Clinical Laboratory Standards, 1994.
	5. Janoir C, Zeller V, Kitzis MD, Moreau NJ, Gutmann L. High-level fluoroquinolone resistance in Streptococcus pneumoniae requires mutation in parC and gyrA. Antimicrob Agents Chemother 1996;40:2760-4.
	6. Song JH, Lee NY, Ichiyama S, Yoshida R, Hirakata Y, Fu W, et al. Spread of drug- resistant Streptococcus pneumoniae in Asian countries: Asian Network for Surveillance of Resistant Pathogens (ANSORP) Study. Clin Infect Dis 1999;28:1206-11.
	7. Jung SI, Kim NY, Son JS, Ki HK, Ko KS, Suh JY, et al. Changing trends in antimicrobial resistance among invasive pneumococcal pathogens an Asian countries: Asian Network for Surveillance of Resistance Pathogen (ANSORP) study. Infect Chemother 2004;36:1- 10. Korean.
	8. Woo JH, Kang JM, Kim YS, Shin WS, Ryu JH, Choi JH, et al. A prospective multicenter study of community-acquired pneumonia in adults with emphasis on bacterial etiology. Korean J Infect Dis 2001;33:1-7. Korean.
	9. Hong JH, Lee HS, Jung SH, Kim GW, Eom KS, Lee JM, et al. Prevalence and clinical outcome of penicillin-resistant pneumococcal pneumonia. Tuberc Respir Dis 2003;54:295- 303. Korean.
	10. Chen DK, McGeer A, de Azavedo JC, Low DE. Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada. Canadian Bacterial Surveillance Network. N Engl J Med 1999;341:233-9.
	11. Song JH, Jung SI, Ko KS, Kim NY, Son JS, Chang HH, et al. High prevalence of antimicrobial resistance among clinical Streptococcus pneumoniae isolates in Asia (an ANSORP study). Antimicrob Agents Chemother 2004;48:2101-7.
	12. Pallares R, Linares J, Vadillo M, Cabellos C, Manresa F, Viladrich PF, et al. Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain. N Engl J Med 1995;333: 474-80.
	13. Plouffe JF, Breiman RF, Facklam RR. Bacteremia with Streptococcus pneumoniae. Implications for therapy and prevention. Franklin County Pneumonia Study Grou- Pseudomonas. JAMA 1996;275:194-8.
	14. Cheong HJ, Hwang BY, Park CW, Kim WJ, Kim MJ, Park SC, et al. Clinical and genetic characteristics of infection by penicillin- resistant Streptococcus pneumonia from community and hospital. Korean J Infect Dis 2001;33:112-22. Korean.
	15. Hwangbo B, Yoon HI, Lee SM, Choi SH, Yoo CG, Lee CT, et al. Clinical characteristics of pneumococcal bacteremia in adults: The effect of penicillin resistance on the mortality of patients with pneumococcal bacteremia. Tuberc Respir Dis 1999;47:184-94. Korean.
	16. Turett GS, Blum S, Fazal BA, Justman JE, Telzak EE. Penicillin resistance and other predictors of mortality in pneumococcal bacteremia in a population with high human immunodeficiency virus seroprevalence. Clin Infect Dis 1999;29:321-7.
	17. Feikin DR, Schuchat A, Kolczak M, Barrett NL, Harrison LH, Lefkowitz L, et al. Mortality from invasive pneumococcal pneumonia in the era of antibiotic resistance, 1995-1997. Am J Public Health 2000;90:223-9.
	18. Harwell JI, Brown RB. The drug-resistant pneumococcus: clinical relevance, therapy, and prevention. Chest 2000;117:530-41.
	19. Song JH, Chang HH, Suh JY, Ko KS, Jung SI, Oh WS, et al. Macrolide resistance and genotypic characterization of Streptococcus pneumoniae in Asian countries: a study of the Asian Network for Surveillance of Resistant Pathogens (ANSORP). J Antimicrob Chemother 2004;53:457-63.